SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (4668)7/1/1998 1:04:00 AM
From: Steve Fancy   of 6136
 
Alanex Corp (NASDAQ:AGPH) in pact with Zeneca unit

Reuters, Thursday, June 18, 1998 at 13:29

LA JOLLA, Calif., June 18 (Reuters) - Pharmaceuticals giant
Alanex Corp. said Thursday it had entered into a three-year
research agreement with Zeneca Agrochemicals, the crop
protection and plant science business of English specialty drug
and chemical company Zeneca Group Plc (ISEL:ZEN).
Under terms of the agreement, Alanex, a wholly-owned
subsidiary of Agouron Pharmaceuticals Inc., will provide
compounds from its exploratory chemical libraries on a
nonexclusive basis for screening in Zeneca's high throughput
agrochemical assays, Alanex said in a statement.
Zeneca will have the right to exclusively license leads
that arise from the use of the Alanex screening libraries for
applications in agriculture, horticulture, forestry and public
health, while Alanex retains all human pharmaceutical and
animal health commercial rights.
In return, Alanex will receive an upfront license fee and
annual research support. The agreement also provides for
milestone and royalty payments to Alanex. Further financial
terms of the agreement were not disclosed.

Copyright 1998, Reuters News Service
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext